TNF and melanoma: More recently, a systematic review and meta-analysis of patients withinflammatory diseases being treated with biologics (mostly TNF-α inhibitors)stated that clinically important increases in melanoma risk cannot be ruled out.52 The hazard ratio (HR) for psoriasis was 1.57 (95% CI 0.61-4.09).